Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adrianna Rossi"'
Autor:
Adolfo Aleman, Morgan van Kesteren, Ariel Kogan Zajdman, Komal Srivastava, Christian Cognigni, Jacob Mischka, Lucia Y. Chen, Bhaskar Upadhyaya, Kseniya Serebryakova, Jessica R. Nardulli, Neko Lyttle, Katerina Kappes, Hayley Jackson, Charles R. Gleason, Annika Oostenink, Gianna Y. Cai, Oliver Van Oekelen, Harm van Bakel, Emilia Mia Sordillo, Carlos Cordon-Cardo, Miriam Merad, Sundar Jagannath, Ania Wajnberg, Viviana Simon, Samir Parekh, Hala Alshammary, Dalles Andre, Radhika Banu, Katherine Beach, María Carolina Bermúdez-González, Ajai Chari, Yuexing Chen, Hearn Cho, Adolfo Firpo, Ana Silvia Gonzalez-Reiche, Eun Hye Kim, Giulio Kleiner, Florian Krammer, Jacob Mauldin, Rao Mendu, Brian Monahan, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adrianna Rossi, Ashley Salimbangon, Laryssa Sanchez, Daniel Verina
Publikováno v:
EBioMedicine, Vol 98, Iss , Pp 104886- (2023)
Summary: Background: The real-world impact of bivalent vaccines for wild type (WA.1) and Omicron variant (BA.5) is largely unknown in immunocompromised patients with Multiple Myeloma (MM). We characterize the humoral and cellular immune responses in
Externí odkaz:
https://doaj.org/article/cc58fda45a4f4326af1b2763e037bc22
Autor:
Dian T. Lo, Priscilla Parra, Kathleen M. Crowley, Ljiljana V. Vasovic, Robert A. DeSimone, Adrianna Rossi, Diana Degtyaryova, Ruchika Goel, Yen-Michael S. Hsu, Melissa M. Cushing, Sabrina E Racine-Brzostek, Meta Morrison
Publikováno v:
Transfusion. 59:1252-1258
BACKGROUND Daratumumab (DARA) is a human IgG1κ monoclonal antibody directed against CD38, approved for the treatment of multiple myeloma. As CD38 is expressed on RBCs, DARA can interfere with pretransfusion testing. DARA interference can be negated
Autor:
Melissa M, Cushing, Robert A, DeSimone, Ruchika, Goel, Yen-Michael S, Hsu, Priscilla, Parra, Sabrina E, Racine-Brzostek, Diana, Degtyaryova, Dian T, Lo, Meta, Morrison, Kathleen M, Crowley, Adrianna, Rossi, Ljiljana V, Vasovic
Publikováno v:
Transfusion. 59(4)
Daratumumab (DARA) is a human IgG1κ monoclonal antibody directed against CD38, approved for the treatment of multiple myeloma. As CD38 is expressed on RBCs, DARA can interfere with pretransfusion testing. DARA interference can be negated by denatura
Publikováno v:
Clinical Chemistry. 65:498-499
A 58-year-old male with kappa Bence Jones proteinuria was referred to our myeloma clinic for renal failure [creatinine level, 2.98 mg/dL (reference interval, 0.64–1.27 mg/dL); calcium level, 10.5 mg/dL (8.7–10.4 mg/dL); and total protein level, 9
Autor:
Richard R. Furman, John M. Bennett, Gail J. Roboz, Morton Coleman, Ellen K. Ritchie, Adrianna Rossi, Komal Jhaveri, Eric J. Feldman, John P. Leonard
Publikováno v:
Leukemia research. 31(8)
Patients with indolent non-Hodgkin lymphoma (I-NHL) often receive multiple courses of cytotoxic chemotherapy over several years. Radioimmunotherapy (RIT) has become an important part of treatment for relapsed patients and tositumomab/lodine I-131 tos